SECSONAR

$HALO

Halozyme Therapeutics, Inc.

NASDAQ

Up 17% since last report

FCF positive · Revenue growing

Price

52-week range $33.32 – $81.23

52w low $33.32Now $77.58

Find before everyone else

SEC filings, insider trades & earnings for HALO — in one place.